LOS ANGELES, CALIFORNIA -- (Marketwired) -- 02/03/15 -- Patient Home Monitoring (PHM) (TSX VENTURE: PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the U.S. and Canada, provided highlights of its financial results for the FY 2014,Q1 FY 2015 and plans for 2015.
To listen to the full interactive conference call please go to the link provided:
https://cc.readytalk.com/play?id=7g53t2
Participants from PHM were Michael Dalsin (Chairman), Roger Greene (Vice Chairman), David Hayes (Incoming CEO), Andrew Folmer (CFO) and Edward Brann (M&A Banker).
About PHM
PHM is an acquisition-oriented, fast-growing and profitable company servicing patients with heart disease and other chronic health conditions. PHM is focused on acquiring companies in a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively identifying and evaluating profitable, annuity-based companies to acquire at favorable prices for their patient databases and technical expertise. PHM's post-acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of PHM and anticipated events or results, are assumptions based on beliefs of PHM's senior management as well as information currently available to it. While these assumptions were considered reasonable by PHM at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, difficulty integrating newly acquired businesses, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected. This press release refers non-GAAP and non-IFRS financial measures that do not have standardized meaning prescribed by GAAP or IFRS. PHM's presentation of these financial measures may not be comparable to similarly titled measures used by other companies. These financial measures are intended to provide additional information to investors concerning PHM's performance.
Contacts:
Patient Home Monitoring Corp.
Dennis Wilson
Corporate Affairs
investorinfo@myphm.com
www.phmhometesting.com
